HK1210967A1 - 用於行為、精神和認知障礙的預防和治療的組合物 - Google Patents
用於行為、精神和認知障礙的預防和治療的組合物Info
- Publication number
- HK1210967A1 HK1210967A1 HK15111940.1A HK15111940A HK1210967A1 HK 1210967 A1 HK1210967 A1 HK 1210967A1 HK 15111940 A HK15111940 A HK 15111940A HK 1210967 A1 HK1210967 A1 HK 1210967A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- behavioural
- prophylaxis
- mental
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012141642A RU2493838C3 (ru) | 2012-10-01 | Комбинация для лечения и профилактики поведенческих, психических, когнитивных и неврологических нарушений при органических заболеваниях цнс | |
PCT/RU2012/000906 WO2014054965A1 (ru) | 2012-10-01 | 2012-11-07 | Комбинация для профилактики и лечения поведенческих, психических и когнитивных расстройств |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1210967A1 true HK1210967A1 (zh) | 2016-05-13 |
Family
ID=49253922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15111940.1A HK1210967A1 (zh) | 2012-10-01 | 2015-12-03 | 用於行為、精神和認知障礙的預防和治療的組合物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9999614B2 (zh) |
EP (1) | EP2905021B1 (zh) |
CN (1) | CN104936584B (zh) |
AU (1) | AU2012391533B2 (zh) |
CA (1) | CA2886011C (zh) |
EA (1) | EA024489B1 (zh) |
HK (1) | HK1210967A1 (zh) |
HU (1) | HUE027934T2 (zh) |
IL (1) | IL238056A (zh) |
UA (1) | UA107653U (zh) |
WO (1) | WO2014054965A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3075038B1 (fr) | 2017-12-15 | 2020-03-06 | Melchior Material And Life Science France | Utilisation de la fluoroethylnormemantine pour la prevention de l'apparition et le traitement de l'anxiete |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4600723A (en) | 1983-05-18 | 1986-07-15 | Monash University | Method for minimizing disturbances in circadian rhythms of bodily performance and function |
DE58905637D1 (de) | 1989-04-14 | 1993-10-21 | Merz & Co Gmbh & Co | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie. |
US5242941A (en) | 1990-12-04 | 1993-09-07 | State Of Oregon | Methods of treating circadian rhythm disorders |
US5614560A (en) | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
US6469044B1 (en) | 1995-02-01 | 2002-10-22 | Neurim Pharmaceuticals (1991) Ltd. | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
PL193237B1 (pl) | 1997-06-30 | 2007-01-31 | Merz Pharma Gmbh & Co Kgaa | Pochodne 1-aminoalkilocykloheksanu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie |
CA2357114C (en) * | 2001-03-22 | 2010-06-29 | Pooger Properties Ltd. | Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder |
CA2426492C (en) | 2002-05-31 | 2006-10-03 | H. Lundbeck A/S | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
CA2500198A1 (en) * | 2002-09-26 | 2004-04-08 | Pooger Properties Limited | Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
UA83645C2 (ru) | 2002-10-24 | 2008-08-11 | Мерц Фарма Гмбх Унд Ко. Кгаа | Фармацевтический продукт, который содержит производное 1-аминоциклогексана и ингибитор ацетилхолинестеразы, его применение |
CN1791423A (zh) | 2003-03-19 | 2006-06-21 | 阿雷斯贸易股份有限公司 | 阿尔茨海默病的治疗 |
KR20070104480A (ko) | 2003-05-27 | 2007-10-25 | 포레스트 래보러토리즈, 인코포레이티드 | 우울증 및 그 밖의 기분장애의 치료를 위한 nmda수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물 |
BRPI0512177A (pt) | 2004-06-17 | 2008-02-12 | Forest Laboratories | formulação de liberação modificada de memantina |
WO2006034465A1 (en) * | 2004-09-23 | 2006-03-30 | Merz Pharma Gmbh & Co. Kgaa | Memantine for the treatment of childhood behavioral disorders |
JP5666087B2 (ja) | 2005-04-06 | 2015-02-12 | アダマス・ファーマシューティカルズ・インコーポレーテッド | Cns関連疾患の治療のための方法及び組成物 |
CA2604617C (en) | 2005-04-28 | 2014-06-17 | Eisai R&D Management Co., Ltd. | Composition containing anti-dementia drug |
CA2607600A1 (en) | 2005-06-16 | 2006-12-28 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
KR20090024140A (ko) * | 2006-05-22 | 2009-03-06 | 반다 파마슈티칼즈, 인코퍼레이티드. | 우울증 질환에 대한 치료 |
BRPI0711872A2 (pt) | 2006-05-22 | 2011-12-06 | Vanda Pharmaceuticals Inc | tratamento para distúrbios depressivos |
WO2008005036A1 (en) | 2006-07-05 | 2008-01-10 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions of memantine |
GB0623897D0 (en) | 2006-11-30 | 2007-01-10 | Pliva Istrazivanje I Razvoj D | Pharmaceutical composition of memantine |
RU2326660C1 (ru) | 2007-03-14 | 2008-06-20 | Закрытое акционерное общество "Биологические исследования и системы" | Пероральный лекарственный препарат мемантин (варианты) и способ его получения (варианты) |
AU2008239683B2 (en) | 2007-04-11 | 2014-03-27 | Pharmaceuticals Productions Inc | Melatonin tablet and methods of preparation and use |
BRPI0811052A2 (pt) | 2007-04-12 | 2015-01-27 | Univ Minnesota | Composições de proteção de isquemia/reperfusão e métodos de uso. |
RU2336062C1 (ru) | 2007-04-23 | 2008-10-20 | Галина Ивановна Должич | Способ лечения сложного миопического астигматизма |
-
2012
- 2012-07-11 UA UAA201502705U patent/UA107653U/uk unknown
- 2012-11-07 EP EP12886074.9A patent/EP2905021B1/en active Active
- 2012-11-07 HU HUE12886074A patent/HUE027934T2/en unknown
- 2012-11-07 CN CN201280077419.6A patent/CN104936584B/zh active Active
- 2012-11-07 EA EA201590547A patent/EA024489B1/ru unknown
- 2012-11-07 WO PCT/RU2012/000906 patent/WO2014054965A1/ru active Application Filing
- 2012-11-07 US US14/432,225 patent/US9999614B2/en active Active
- 2012-11-07 AU AU2012391533A patent/AU2012391533B2/en active Active
- 2012-11-07 CA CA2886011A patent/CA2886011C/en active Active
-
2015
- 2015-03-31 IL IL238056A patent/IL238056A/en active IP Right Grant
- 2015-12-03 HK HK15111940.1A patent/HK1210967A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUE027934T2 (en) | 2016-11-28 |
RU2493838C1 (ru) | 2013-09-27 |
UA107653U (uk) | 2016-06-24 |
US20150250763A1 (en) | 2015-09-10 |
CA2886011A1 (en) | 2014-04-10 |
EP2905021A4 (en) | 2015-08-12 |
AU2012391533A1 (en) | 2015-05-07 |
CA2886011C (en) | 2018-01-16 |
EA201590547A1 (ru) | 2015-07-30 |
WO2014054965A1 (ru) | 2014-04-10 |
EP2905021B1 (en) | 2016-04-27 |
CN104936584B (zh) | 2017-12-15 |
IL238056A (en) | 2017-09-28 |
US9999614B2 (en) | 2018-06-19 |
EP2905021A1 (en) | 2015-08-12 |
CN104936584A (zh) | 2015-09-23 |
AU2012391533B2 (en) | 2017-04-06 |
EA024489B1 (ru) | 2016-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201503042B (en) | Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders | |
EP3068289A4 (en) | Prevention and treatment of bed exits, falls, and other conditions | |
EP2827856A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES | |
HK1207860A1 (zh) | 用於治療糖尿病及其相關病症的 -苯基- -雜環基-四氫- -吡喃- -胺化合物 | |
EP2819587A4 (en) | METHODS, APPARATUSES AND SYSTEMS FOR DIAGNOSING AND TREATING MOOD DISORDERS | |
IL280144A (en) | Use of telomerase inhibitors to treat bone marrow culture disorders and bone marrow culture tumors | |
EP2867239A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES | |
HK1205467A1 (zh) | 用於預防和治療精神、行為和認知障礙的藥物組合物 | |
HK1207593A1 (zh) | 用於治療精神和行為病症的藥物 | |
ZA201607980B (en) | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms | |
IL235127A (en) | Hpn-100 for use in the treatment of nitrogen-related diseases | |
HK1203054A1 (zh) | 治療疼痛的二核苷多磷酸鹽 | |
ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
IL237912A0 (en) | History of dihydro-6-azaphenylene for the treatment of the central nervous system, oncological diseases and similar disorders | |
ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
HK1210967A1 (zh) | 用於行為、精神和認知障礙的預防和治療的組合物 | |
GB201219696D0 (en) | Agents for the prevention and/or treatment of central nervous system damamge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: CORRECTION OF THE CHINESE NAME OF INVENTOR FROM |